Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
40%(2 trials)

Phase Distribution

Ph phase_2
1
20%
Ph phase_1
2
40%
Ph phase_4
1
20%
Ph phase_3
1
20%

Phase Distribution

2

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (40.0%)
Phase 21 (20.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_1

General Anesthesia Emergence Induced by Methylphenidate

NCT02327195
completedphase_4

Treatment of Severe Childhood Aggression (The TOSCA Study)

NCT00796302
completedphase_1

A Pharmacokinetics and Safety of Methylphenidate HCl in Healthy Japanese Adult Male Volunteers

NCT01202734
completedphase_2

Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients

NCT00664703
completedphase_3

Long-term Safety and Effectiveness of OROS Methylphenidate HCl in Children With Attention Deficit Hyperactivity Disorder

NCT00269815

Clinical Trials (5)

Showing 5 of 5 trials
NCT02327195Phase 1

General Anesthesia Emergence Induced by Methylphenidate

Completed
NCT00796302Phase 4

Treatment of Severe Childhood Aggression (The TOSCA Study)

Completed
NCT01202734Phase 1

A Pharmacokinetics and Safety of Methylphenidate HCl in Healthy Japanese Adult Male Volunteers

Completed
NCT00664703Phase 2

Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients

Completed
NCT00269815Phase 3

Long-term Safety and Effectiveness of OROS Methylphenidate HCl in Children With Attention Deficit Hyperactivity Disorder

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5